Executives at the forefront of healthcare technology will share their perspective on the state of AI in healthcare. They will cover hype vs reality; more and less promising segments; roadblocks to be overcome; consumer vs enterprise as beachhead; role of various ecosystem players; and regulatory and societal implications.
Moderator: Dr. Pallav Sharda is the author of "Before Disrupting Healthcare: What Innovators Need to Know.” Leading healthcare technologists have called his book “a pocket guide to the system” and described Dr. Sharda as having “an uncanny ability to both summarize and dissect a very complicated byzantine ecosystem that is ripe for true innovation using technology.”
Previously, he was the Director of Health IT Interoperability initiatives at Omnicell, Inc; led Product Management team for Health Information Exchange (HIE) solutions at UnitedHealth Group; worked on Clinical Data Analytics and Population Health Management technology initiatives at Kaiser Permanente; worked in GE Healthcare’s Electronic Health Record (EHR) business; and taught at the graduate Medical Informatics program at Northwestern University. Dr. Sharda received his MBA from Northwestern University (IL), Masters in Medical Informatics from Columbia University (NY), and a Bachelors of Medicine and Surgery (MBBS) from Delhi University (India).
Dr. James Golden
Dr. Golden is a Senior Managing Director for PwC’s Healthcare Advisory and Healthcare IT Practice. His work focuses on identifying and utilizing new data sources, technologies, and analytics methods for PwC’s clients to drive decision making and optimize healthcare practices. Dr. Golden works across the healthcare ecosystem, focusing on technology strategies for organizations working in R&D and translational medicine, clinical trials and precision medicine, patient care delivery, and population health. He has a formal education in machine learning and artificial intelligence. Dr. Golden is an angel investor and advisor to startups focused on healthcare data analytics, primarily in Boston and NYC.
Professor Surya Ganguli Professor Surya Ganguli is an assistant professor in the Department of Applied Physics at Stanford University, with courtesy appointments in Neurobiology and Electrical Engineering. He and his lab work at the intersection of physics, neuroscience, and machine learning to understand how neural circuits, both biological and artificial, learn and compute. He has earned several awards including a Sloan Fellowship, Burroughs Wellcome Career Award at the Scientific Interface, a McKnight award in neuroscience, a James S. McDonnell Foundation award in human cognition, and a Simons Investigator award in biophysics. Previously, Surya was an undergraduate at MIT, where he triple majored in Mathematics, Physics, and EECS, and a graduate student at Berkeley where he a completed a Ph.D. in String Theory.
Kevin Appelbaum, CEO, Farewell
Kevin Appelbaum is co-founder, CEO & Board Director for FareWell, a digital lifestyle medicine company developing new therapies for the treatment and reversal of diabetes, heart disease and other chronic conditions. He has been an active entrepreneur for more than 20 years, building and leading multiple transformative companies at the intersection of traditional consumer and healthcare industries.
Previously, he served as CEO & Board Director for Tria Beauty, Inc. from 2008 to 2014, a period of explosive growth, from early technology and clinical stage product development into global commercial operations and revenue generation across a portfolio of award-winning, FDA regulated consumer skincare devices. He has also served as a board director for ConsumerMed.org and Ventus Medical, Inc., and was an active member in the Young President's Organization from 1999 - 2012.
Kevin holds a B.S. in chemical engineering from the University of Pennsylvania. Following graduation, he served peacetime and combat assignments as an officer in the U.S. Army Rangers.
Previously, he served as CEO & Board Director for Tria Beauty, Inc. from 2008 to 2014, a period of explosive growth, from early technology and clinical stage product development into global commercial operations and revenue generation across a portfolio of award-winning, FDA regulated consumer skincare devices. He has also served as a board director for ConsumerMed.org and Ventus Medical, Inc., and was an active member in the Young President's Organization from 1999 - 2012.
Kevin holds a B.S. in chemical engineering from the University of Pennsylvania. Following graduation, he served peacetime and combat assignments as an officer in the U.S. Army Rangers.
